- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Non-alcoholic Fatty Liver Disease (NAFLD) in New Zealand
Total 279 results
-
GenfitPremier Research Group plc; NaturalphaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom
-
Genentech, Inc.TerminatedNon-alcoholic SteatohepatitisBelgium, United States, Spain, Puerto Rico, France
-
Mirum Pharmaceuticals, Inc.TerminatedNon-Alcoholic SteatohepatitisUnited States, United Kingdom, Canada, Puerto Rico
-
PfizerCompleted
-
Northwell HealthTerminatedNon-Alcoholic Fatty Liver Disease | Probiotics MeSH Descriptor Data 2018 | Interleukin-17 MeSH Descriptor Data 2018United States
-
Institute of Liver and Biliary Sciences, IndiaRecruitingMetabolic Syndrome | Non-Alcoholic Fatty Liver DiseaseIndia
-
Cirius Therapeutics, Inc.Chiltern International Inc.CompletedNon-alcoholic Fatty Liver Disease | NASH - Nonalcoholic Steatohepatitis | Non-alcoholic SteatohepatitisUnited States
-
AstraZenecaCompletedNon-cirrhotic Non-alcoholic Steatohepatitis With FibrosisUnited States, Austria, Italy, Thailand, Germany, Korea, Republic of, Japan, Malaysia, New Zealand, Spain, Taiwan, Turkey, Australia, Israel, Argentina, Canada, Greece, South Africa, United Kingdom, France
-
Institute of Liver and Biliary Sciences, IndiaCompletedLiver CirrhosisIndia
-
Conatus Pharmaceuticals Inc.CompletedLiver Diseases | Fibrosis | Non-alcoholic SteatohepatitisUnited States, Spain, Germany
-
Novo Nordisk A/SCompletedNon-alcoholic Steatohepatitis | Hepatobiliary DisordersUnited States, Russian Federation, United Kingdom, Denmark, Sweden, Netherlands, Austria, Belgium, Spain, France, Bulgaria, Canada, Australia, Greece, Japan, Finland, Puerto Rico
-
Altimmune, Inc.RecruitingNon-Alcoholic Steatohepatitis (NASH)Australia, United States, Puerto Rico
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruiting
-
Poxel SACompletedNonalcoholic Fatty LiverUnited States
-
Novartis PharmaceuticalsTerminatedNon Alcoholic Steatohepatitis (NASH)United States, South Africa, Spain, Germany, Italy, Taiwan, Canada, Korea, Republic of, Singapore, Bulgaria, Estonia, Mexico, Japan, Denmark, United Kingdom, Colombia, Brazil, Belgium, Russian Federation, Puerto Rico, Chile, Argen... and more
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH) | Primary Sclerosing Cholangitis (PSC)United States, New Zealand
-
Boehringer IngelheimCompletedNon-alcoholic Fatty Liver DiseaseUnited States, Spain, United Kingdom, Belgium, Canada, Germany, Netherlands, France, Ireland
-
Dartmouth-Hitchcock Medical CenterCompletedHepatic Steatosis | Nonalcoholic Fatty Liver Disease | SteatohepatitisUnited States
-
Novartis PharmaceuticalsAllerganCompletedNon-alcoholic Steatohepatitis (NASH)United States, Belgium, Spain, Canada, Argentina, Israel, Germany, France, Italy, Turkey, Singapore, Russian Federation, United Kingdom, Czechia, Egypt, India, Latvia
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)Canada, United States, Hong Kong, United Kingdom, Switzerland, New Zealand
-
AstraZenecaCompletedNon-Cirrhotic Non-alcoholic Steatohepatitis With FibrosisDenmark, Italy, Spain, United States, Argentina, Sweden, Mexico, Norway, Portugal
-
Axcella Health, IncRecruitingNon Alcoholic Steatohepatitis (NASH)United States, Canada, United Kingdom, Australia, France, Poland, Puerto Rico
-
Institute of Liver and Biliary Sciences, IndiaWithdrawn
-
Merck Sharp & Dohme LLCCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States, Argentina, Australia, Canada, France, Israel, Italy, Korea, Republic of, Mexico, New Zealand, Poland, Russian Federation, Spain, Taiwan, Turkey, Ukraine
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedDiabetes Mellitus, Type 2 | NAFLD | Hypertriglyceridemia | Fatty Liver, NonalcoholicUnited States, Canada
-
Columbia UniversityUniversity of California, BerkeleyRecruitingInsulin Resistance | Prediabetic State | Hyperinsulinemia | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Icahn School of Medicine at Mount SinaiNational Institutes of Health (NIH)CompletedNASH - Nonalcoholic Steatohepatitis | Steatosis of LiverUnited States
-
CelgeneTerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver DiseaseUnited States, Spain, Australia, Korea, Republic of, Canada, Germany, France, Japan, United Kingdom, Poland
-
Target PharmaSolutions, Inc.RecruitingNonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States, Germany, Spain
-
Icahn School of Medicine at Mount SinaiCompletedNonalcoholic Fatty Liver DiseaseUnited States
-
GlaxoSmithKlineRecruitingNonalcoholic Fatty Liver DiseaseUnited States, Australia, Italy, Japan, Spain, Belgium, Argentina, Canada, United Kingdom, Korea, Republic of, France, Greece, India, Mexico, Puerto Rico, Turkey, Panama
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHypertriglyceridemia | Steatohepatitis | Non Alcoholic Fatty Liver Disease | Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1United States
-
Enyo PharmaCompletedHealthy | NASH - Nonalcoholic SteatohepatitisAustralia
-
Madrigal Pharmaceuticals, Inc.RecruitingNon-Alcoholic Fatty Liver DiseaseUnited States, Puerto Rico
-
Madrigal Pharmaceuticals, Inc.CompletedNon-Alcoholic Fatty Liver DiseaseUnited States, Puerto Rico
-
Sagimet Biosciences Inc.CompletedNonalcoholic Fatty Liver DiseaseUnited States, Canada, Puerto Rico, Poland
-
89bio, Inc.ProSciento, Inc.Completed
-
Conatus Pharmaceuticals Inc.CompletedNon-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
Blade TherapeuticsCompletedNASH - Nonalcoholic Steatohepatitis | Chronic Liver DiseaseAustralia
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Albert...RecruitingObesity | Insulin Resistance | Prediabetic State | Hyperinsulinemia | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Far Eastern Memorial HospitalMinistry of Science and Technology, TaiwanRecruiting
-
Gilead SciencesNovo Nordisk A/SCompletedNonalcoholic SteatohepatitisUnited States
-
PerspectumRecruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
Merck Sharp & Dohme LLCTerminatedNonalcoholic SteatohepatitisKorea, Republic of, United States, Argentina, Australia, Canada, Chile, China, Colombia, France, Germany, Greece, Hong Kong, Israel, Italy, Japan, Malaysia, Mexico, New Zealand, Puerto Rico, Russian Federation, Spain, Sweden, Taiwan, ...
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisHong Kong, United States, Australia, Puerto Rico, New Zealand, Canada
-
Galmed Research and Development, Ltd.Medical University of Graz; Tel-Aviv Sourasky Medical Center; Fondazione IRCCS... and other collaboratorsCompletedLiver Diseases | Fatty Liver | Non-Alcoholic Steatohepatitis | Liver FibrosesUnited States, Chile, Israel, Italy, France, Germany, Mexico, Georgia, Lithuania, Hong Kong, Romania
-
Gilead SciencesTerminatedLiver Fibrosis Due to NASHUnited States, Spain, France, Canada, Germany, Italy, Puerto Rico, United Kingdom, Belgium
-
AstraZenecaRecruitingNon-alcoholic Steatohepatitis (NASH)Austria, Germany, Japan, Sweden
-
Gilead SciencesCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Canada
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)United States